$34.190
-0.403 (-1.18%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
VERA Prediction & Forecast by Similar Chart Analysis
Alphio's VERA stock price prediction model matches the current Vera Therapeutics, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $34.35 (+0.48%). The 1-week path is $33.69 (-1.46%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Vera Therapeutics, Inc Stock?
Vera Therapeutics is a good buy right now due to its recent FDA accelerated approval for TRUTAKNA, which demonstrated a 46% reduction in proteinuria, a significant advancement in treating chronic kidney disease. The current price of $34.19 is well below the average analyst price target of $76, indicating substantial upside potential. However, the company has reported a negative EPS of -1.52, which highlights ongoing financial challenges that investors should consider.
VERA stock price ended at $34.19 on Friday, after losing -1.18%
Vera Therapeutics, Inc (VERA) last closed at $34.19, losing -1.18%. These facts feed the 1-day and 1-week VERA price prediction above.
Forecast Drivers
Vera Therapeutics, Inc (VERA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches VERA, ranked by similarity.
Seasonality analysis for VERA
Historically the probability of a positive August return for VERA is 34.92%. December offers the highest probability of a positive month at 93.02%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for VERA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $22.73 | $24.44 | $25.33 | -28.50% |
| Sep 2026 | $23.47 | $25.62 | $26.43 | -25.06% |
| Oct 2026 | $25.20 | $25.98 | $26.53 | -24.00% |
| Nov 2026 | $19.27 | $21.73 | $22.77 | -36.46% |
| Dec 2026 | $25.98 | $26.83 | $27.91 | -21.54% |
In 2026, Vera Therapeutics, Inc (VERA) is projected to range from $19.27 to $27.91.
Vera Therapeutics, Inc 2026 monthly forecast
In Aug 2026, Vera Therapeutics, Inc is projected to average $24.44, with a low of $22.73 and high of $25.33.
In Sep 2026, Vera Therapeutics, Inc is projected to average $25.62, with a low of $23.47 and high of $26.43.
In Oct 2026, Vera Therapeutics, Inc is projected to average $25.98, with a low of $25.20 and high of $26.53.
In Nov 2026, Vera Therapeutics, Inc is projected to average $21.73, with a low of $19.27 and high of $22.77.
In Dec 2026, Vera Therapeutics, Inc is projected to average $26.83, with a low of $25.98 and high of $27.91.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.